Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aplisol vs PPD-S2 Specificity Equivalence Study
NCT01798095Phase 2Unknown
- Sponsor
- JHP Pharmaceuticals
- Start
- Feb 2013
- Primary completion
- May 2013
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tuberculin purified protein derivative in Tuberculosis (TB), sponsored by JHP Pharmaceuticals. Primary endpoint: Similarity in responses at 72 hours. Status: unknown.
02
Drugs
tuberculin purified protein derivative
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01798095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798095.